Matsuno K, Ishihara R, Ohmori M et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol 2019;54:784–791. https://doi.org/10.1007/s00535-019-01577-7.

Article  CAS  PubMed  Google Scholar 

Sugano K, Spechler SJ, El-Omar EM et al. Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction. Gut 2022;71:1488–1514. https://doi.org/10.1136/gutjnl-2022-327281.

Article  PubMed  Google Scholar 

Imamura Y, Watanabe M, Oki E et al. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study. Ann Gastroenterol Surg 2021;5:46–59. https://doi.org/10.1002/ags3.12406.

Article  PubMed  Google Scholar 

Chevallay M, Bollschweiler E, Chandramohan SM et al. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci 2018;1434:132–138. https://doi.org/10.1111/nyas.13954.

Article  PubMed  Google Scholar 

Goel S, Bergholz JS, Zhao JJ. Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer 2022;22:356–372. https://doi.org/10.1038/s41568-022-00456-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Xu D, Li X et al. Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future. J Cancer 2019;10:6608–6617. https://doi.org/10.7150/jca.33079.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rader J, Russell MR, Hart LS et al. Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin Cancer Res 2013;19:6173–6182. https://doi.org/10.1158/1078-0432.Ccr-13-1675.

Article  CAS  PubMed  Google Scholar 

Zeng F, Zhou Y, Khowtanapanich T et al. Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract. In Vivo 2022;36:1580–1590. https://doi.org/10.21873/invivo.12868.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bar-Sela G, Hershkovitz D, Haim N et al. The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel. Oncol Lett 2013;5:559–563. https://doi.org/10.3892/ol.2012.1031.

Article  PubMed  Google Scholar 

Cizkova K, Foltynkova T, Gachechiladze M et al. Comparative Analysis of Immunohistochemical Staining Intensity Determined by Light Microscopy, ImageJ and QuPath in Placental Hofbauer Cells. Acta Histochem Cytochem 2021;54:21–29. https://doi.org/10.1267/ahc.20-00032.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu A, Wu B, Guo J et al. Elevated expression of CDK4 in lung cancer. J Transl Med 2011;9:38. https://doi.org/10.1186/1479-5876-9-38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang LH, Contractor T, Clausen R et al. Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6. Clin Cancer Res 2012;18:4612–4620. https://doi.org/10.1158/1078-0432.Ccr-11-3264.

Article  CAS  PubMed  Google Scholar 

Poomsawat S, Buajeeb W, Khovidhunkit SO et al. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. J Oral Pathol Med 2010;39:793–799. https://doi.org/10.1111/j.1600-0714.2010.00909.x.

Article  PubMed  Google Scholar 

Lam PY, Di Tomaso E, Ng HK et al. Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme. Br J Neurosurg 2000;14:28–32. https://doi.org/10.1080/02688690042870.

Article  CAS  PubMed  Google Scholar 

Li F, Xu Y, Liu B et al. YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer. Clin Cancer Res 2019;25:2264–2277. https://doi.org/10.1158/1078-0432.Ccr-18-1029.

Article  CAS  PubMed  Google Scholar 

Takano Y, Kato Y, van Diest PJ et al. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 2000;156:585–594. https://doi.org/10.1016/s0002-9440(10)64763-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li LP, Wu WJ, Sun DY et al. miR-449a and CDK6 in gastric carcinoma. Oncol Lett 2014;8:1533–1538. https://doi.org/10.3892/ol.2014.2370.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cameron AJ, Lomboy CT, Pera M et al. Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology 1995;109:1541–1546. https://doi.org/10.1016/0016-5085(95)90642-8.

Article  CAS  PubMed  Google Scholar 

Jomrich G, Paireder M, Kristo I et al. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma. Ann Surg 2021;273:532–541. https://doi.org/10.1097/sla.0000000000003370.

Article  PubMed  Google Scholar 

Lagarde SM, ten Kate FJ, Reitsma JB et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2006;24:4347–4355. https://doi.org/10.1200/jco.2005.04.9445.

Article  PubMed  Google Scholar 

von Rahden BH, Stein HJ, Feith M et al. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol 2005;23:874–879. https://doi.org/10.1200/jco.2005.12.151.

Article  Google Scholar 

Liu X, Jiang Q, Yue C et al. Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study. Int J Gen Med 2021;14:10303–10314. https://doi.org/10.2147/ijgm.S341405.

Article  PubMed  PubMed Central  Google Scholar 

Malumbres M, Sotillo R, Santamaría D et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004;118:493–504. https://doi.org/10.1016/j.cell.2004.08.002.

Article  CAS  PubMed  Google Scholar 

Shinkawa H, Tanaka S, Kabata D et al. The Prognostic Impact of Tumor Differentiation on Recurrence and Survival after Resection of Hepatocellular Carcinoma Is Dependent on Tumor Size. Liver Cancer 2021;10:461–472. https://doi.org/10.1159/000517992.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Q, Qin H, Xiao J et al. Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy. Gastroenterol Rep (Oxf) 2019;7:283–290. https://doi.org/10.1093/gastro/goy045.

Article  PubMed  Google Scholar 

Badovinac D, Goričar K, Zavrtanik H et al (2021) Plasma Extracellular Vesicle Characteristics Correlate with Tumor Differentiation and Predict Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgery with Curative Intent. J Pers Med 11. https://doi.org/10.3390/jpm11020077

Rice TW, Patil DTBlackstone EH (2017) 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 6: 119–130. https://doi.org/10.21037/acs.2017.03.14

Molenaar JJ, Ebus ME, Koster J et al. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 2008;68:2599–2609. https://doi.org/10.1158/0008-5472.Can-07-5032.

Article  CAS  PubMed  Google Scholar 

Chen SH, Zhang BY, Zhou B et al. Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. Am J Cancer Res 2019;9:1–21.

PubMed  PubMed Central  Google Scholar 

Shin HI, Bang JI, Kim GJ et al (2023) Perineural Invasion Predicts Local Recurrence and Poor Survival in Laryngeal Cancer. J Clin Med 12. https://doi.org/10.3390/jcm12020449

Quintana D, Dedivitis RA, Kowalski LP. Prognostic impact of perineural invasion in oral cancer: a systematic review. Acta Otorhinolaryngol Ital 2022;42:17–25. https://doi.org/10.14639/0392-100x-n1653.